5-hydroxytryptamine in psychiatry: a spectrum of ideas
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Oxford u.a.
Oxford Univ. Press
1991
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII, 349 S. |
| ISBN: | 0192620118 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV004686759 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 920124s1991 |||| 10||| engod | ||
| 020 | |a 0192620118 |9 0-19-262011-8 | ||
| 035 | |a (OCoLC)22243060 | ||
| 035 | |a (DE-599)BVBBV004686759 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-578 | ||
| 050 | 0 | |a RC455.4.B5 | |
| 082 | 0 | |a 616.89/18 |2 20 | |
| 245 | 1 | 0 | |a 5-hydroxytryptamine in psychiatry |b a spectrum of ideas |c ed. by Merton Sandler |
| 246 | 1 | 3 | |a Five-hydroxytryptamine in psychiatry |
| 264 | 1 | |a Oxford u.a. |b Oxford Univ. Press |c 1991 | |
| 300 | |a XIII, 349 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 2 | |a Récepteur sérotonine - Physiologie - Congrès | |
| 650 | 2 | |a Sérotonine - Physiologie - Congrès comme sujet | |
| 650 | 2 | |a Sérotonine - usage thérapeutique - Congrès comme sujet | |
| 650 | 2 | |a Trouble mental - Chimiothérapie - Congrès | |
| 650 | 2 | |a Trouble mental - Etiologie - Congrès | |
| 650 | 4 | |a Mental Disorders |x drug therapy |v Congresses | |
| 650 | 4 | |a Mental Disorders |x etiology |v Congresses | |
| 650 | 4 | |a Mental illness |x Physiological aspects |v Congresses | |
| 650 | 4 | |a Neuropsychiatry |v Congresses | |
| 650 | 4 | |a Receptors, Serotonin |x physiology |v Congresses | |
| 650 | 4 | |a Serotonin |v Congresses | |
| 650 | 4 | |a Serotonin |x physiology |v Congresses | |
| 650 | 4 | |a Serotonin |x therapeutic use |v Congresses | |
| 650 | 0 | 7 | |a Serotonin |0 (DE-588)4054614-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakologie |0 (DE-588)4176249-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1990 |z San Juan Puerto Rico |2 gnd-content | |
| 689 | 0 | 0 | |a Serotonin |0 (DE-588)4054614-7 |D s |
| 689 | 0 | 1 | |a Psychopharmakologie |0 (DE-588)4176249-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Sandler, Merton |d 1926-2014 |e Sonstige |0 (DE-588)119256541 |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002878562&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002878562 | ||
Datensatz im Suchindex
| _version_ | 1804118803687145472 |
|---|---|
| adam_text | 5-HYDROXYTRYPTAMINE IN PSYCHIATRY A SPECTRUM OF IDEAS EDITED BY MERTON
SANDIER ALEC COPPEN AND SARA HARNETT OXFORD NEW YORK TOKYO OXFORD
UNIVERSITY PRESS 1991 ** CONTENTS LIST OF CONTRIBUTORS IX 1.
INTRODUCTION. 1 M. SANDIER 2. AN OVERVIEW OF 5-HYDROXYTRYPTAMINE
RECEPTOR FAMILIES. 2 S. J. PEROUTKA AND A. W. SCHMIDT DISCUSSION 3. AN
OVERVIEW OF SEROTONIN NEUROCHEMISTRY AND NEUROANATOMY. 23 D. L. MURPHY
DISCUSSION 4. MILACEMIDE: A NEUROPSYCHOTROPIC GLYCINE PRODRUG THAT
POTENTIATES SEROTONERGIC ACTIVITY. 37 M. B. H. YOUDIM DISCUSSION 5. THE
INACTIVE ENANTIOMER OF A NORADRENALIN UPTAKE BLOCKER REDUCES 5-HT
SYNTHESIS. 43 P. C. WALDMEIER AND L. MAITRE DISCUSSION 6. PLATELET
SEROTONIN STUDIES IN AFFECTIVE DISORDERS: EVIDENCE FOR A SEROTONERGIC
ABNORMALITY? 50 H. Y. MELTZER AND R. C. ARORA DISCUSSION 7. THE ROLE OF
5-HT IN MIGRAINE: DISENTANGLING THE LINKS WITH DEPRESSION. 90 V. GLOVER,
J. JARMAN, AND M. SANDIER DISCUSSION VI CONTENTS 8. THE ACUTE EFFECT OF
MONOAMINE OXIDASE INHIBITORS ON SEROTONIN CONVERSION TO MELATONIN. 98 G.
F. OXENKRUG 9. STIMULATION OF RAT PINEAL MELATONIN SYNTHESIS BY A SINGLE
ELECTROCONVULSIVE SHOCK: CHRONOBIOLOGICAL EFFECT OF ANTIDEPRESSANT
THERAPY? 110 G. F OXENKRUG, P. J. REQUINTINA, I. M. MCLNTYRE, AND R.
DAVIS 10. CAMP-DEPENDENT BINDING PROTEINS AND ENDOGENOUS PHOSPHORYLATION
AFTER ANTIDEPRESSANT TREATMENT. 116 G. RACAGNI, D. TINELLI, E. BIANCHI,
N. BRUNELLO, AND J. PEREZ 11. ABNORMAL 5-HT NEUROENDOCRINE FUNCTION IN
DEPRESSION: ASSOCIATION OR ARTEFACT? 124 P. J. COWEN AND I. M. ANDERSON
DISCUSSION 12. EXPERIMENTAL TESTS OF THE 5-HT RECEPTOR IMBALANCE THEORY
OF AFFECTIVE DISTURBANCE. 143 /. F. W. DEAKIN, F. S. GUIMARAES, M. WANG,
AND R. HENSMAN DISCUSSION 13. ANTIDEPRESSANT EFFICACY OF 5-HT 1A PARTIAL
AGONIST DRUGS. 157 D. S. ROBINSON DISCUSSION 14. NEUROENDOCRINE
SEROTONERGIC CHALLENGES IN CLINICAL RESEARCH. , 166 /. /. LOPEZ-IBOR JR,
J. SAIZ-RUIZ, L. MORAL, I. MORENO, AND R. VINAS DISCUSSION 15. SEROTONIN
IN ANXIETY: EVIDENCE FROM ANIMAL MODELS. 177 . M. BRILEY AND P. CHOPIN
DISCUSSION 16. ANXIOGENIC EFFECT OF THE 5-HT LC AGONIST M-
CHLOROPHENYLPIPERAZINE. 198 G. CURZON, G. A. KENNETT, AND P. WHITTON
DISCUSSION CONTENTS VII 17. DOES 5-HT HAVE A ROLE IN ANXIETY AND THE
ACTION OF ANXIOLYTICS? 207 M. PALFREYMAN AND]. H. KEHNE DISCUSSION 18.
SEROTONIN IN OBSESSIVE-COMPULSIVE DISORDER: A CAUSAL CONNECTION OR MORE
MONOMANIA ABOUT A MAJOR MONOAMINE? 228 T. R. INSEL DISCUSSION 19.
MONOAMINES, GLUCOSE METABOLISM, AND IMPULSE CONTROL. 258 M. LINNOILA AND
M. VIRKKUNEN DISCUSSION 20. 5-HYDROXYTRYPTAMINE IN THE CONTROL OF
FEEDING AND ITS POSSIBLE IMPLICATIONS FOR APPETITE DISTURBANCE. 279 G.
CURZON DISCUSSION 21. D-FENFLURAMINE AND ANIMAL MODELS OF EATING
DISORDERS. 303 B. GUARDIOLA-LEMAITRE 22. DISTURBANCE OF THE
5-HYDROXYTRYPTAMINE METABOLISM IN AGEING AND IN ALZHEIMER S AND VASCULAR
DEMENTIAS. 309 C. G. GOTTFRIES DISCUSSION 23. 5-HT 3 RECEPTOR
ANTAGONISTS AND THEIR POTENTIAL IN PSYCHIATRIC DISORDERS. 324 M. G.
PALFREYMAN, S. M. SORENSON, A. A. CARR, H. C. CHENG, AND M. W. DUDLEY
24. ATYPICAL ANTIPSYCHOTIC DRUGS: THE 5-HT 2 /DA 2 RATIO. 331 H. Y.
MELTZER DISCUSSION VIII CONTENTS 25. SUMMARY. 336 A. CARLSSON INDEX 341
|
| any_adam_object | 1 |
| author_GND | (DE-588)119256541 |
| building | Verbundindex |
| bvnumber | BV004686759 |
| callnumber-first | R - Medicine |
| callnumber-label | RC455 |
| callnumber-raw | RC455.4.B5 |
| callnumber-search | RC455.4.B5 |
| callnumber-sort | RC 3455.4 B5 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)22243060 (DE-599)BVBBV004686759 |
| dewey-full | 616.89/18 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89/18 |
| dewey-search | 616.89/18 |
| dewey-sort | 3616.89 218 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02215nam a2200529 c 4500</leader><controlfield tag="001">BV004686759</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920124s1991 |||| 10||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0192620118</subfield><subfield code="9">0-19-262011-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)22243060</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004686759</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC455.4.B5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/18</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">5-hydroxytryptamine in psychiatry</subfield><subfield code="b">a spectrum of ideas</subfield><subfield code="c">ed. by Merton Sandler</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Five-hydroxytryptamine in psychiatry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford u.a.</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 349 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Récepteur sérotonine - Physiologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Sérotonine - Physiologie - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Sérotonine - usage thérapeutique - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Trouble mental - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Trouble mental - Etiologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">etiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental illness</subfield><subfield code="x">Physiological aspects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropsychiatry</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, Serotonin</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Serotonin</subfield><subfield code="0">(DE-588)4054614-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1990</subfield><subfield code="z">San Juan Puerto Rico</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Serotonin</subfield><subfield code="0">(DE-588)4054614-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sandler, Merton</subfield><subfield code="d">1926-2014</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)119256541</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002878562&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002878562</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1990 San Juan Puerto Rico gnd-content |
| genre_facet | Konferenzschrift 1990 San Juan Puerto Rico |
| id | DE-604.BV004686759 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T16:16:06Z |
| institution | BVB |
| isbn | 0192620118 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002878562 |
| oclc_num | 22243060 |
| open_access_boolean | |
| owner | DE-12 DE-578 |
| owner_facet | DE-12 DE-578 |
| physical | XIII, 349 S. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Oxford Univ. Press |
| record_format | marc |
| spelling | 5-hydroxytryptamine in psychiatry a spectrum of ideas ed. by Merton Sandler Five-hydroxytryptamine in psychiatry Oxford u.a. Oxford Univ. Press 1991 XIII, 349 S. txt rdacontent n rdamedia nc rdacarrier Récepteur sérotonine - Physiologie - Congrès Sérotonine - Physiologie - Congrès comme sujet Sérotonine - usage thérapeutique - Congrès comme sujet Trouble mental - Chimiothérapie - Congrès Trouble mental - Etiologie - Congrès Mental Disorders drug therapy Congresses Mental Disorders etiology Congresses Mental illness Physiological aspects Congresses Neuropsychiatry Congresses Receptors, Serotonin physiology Congresses Serotonin Congresses Serotonin physiology Congresses Serotonin therapeutic use Congresses Serotonin (DE-588)4054614-7 gnd rswk-swf Psychopharmakologie (DE-588)4176249-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1990 San Juan Puerto Rico gnd-content Serotonin (DE-588)4054614-7 s Psychopharmakologie (DE-588)4176249-6 s DE-604 Sandler, Merton 1926-2014 Sonstige (DE-588)119256541 oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002878562&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | 5-hydroxytryptamine in psychiatry a spectrum of ideas Récepteur sérotonine - Physiologie - Congrès Sérotonine - Physiologie - Congrès comme sujet Sérotonine - usage thérapeutique - Congrès comme sujet Trouble mental - Chimiothérapie - Congrès Trouble mental - Etiologie - Congrès Mental Disorders drug therapy Congresses Mental Disorders etiology Congresses Mental illness Physiological aspects Congresses Neuropsychiatry Congresses Receptors, Serotonin physiology Congresses Serotonin Congresses Serotonin physiology Congresses Serotonin therapeutic use Congresses Serotonin (DE-588)4054614-7 gnd Psychopharmakologie (DE-588)4176249-6 gnd |
| subject_GND | (DE-588)4054614-7 (DE-588)4176249-6 (DE-588)1071861417 |
| title | 5-hydroxytryptamine in psychiatry a spectrum of ideas |
| title_alt | Five-hydroxytryptamine in psychiatry |
| title_auth | 5-hydroxytryptamine in psychiatry a spectrum of ideas |
| title_exact_search | 5-hydroxytryptamine in psychiatry a spectrum of ideas |
| title_full | 5-hydroxytryptamine in psychiatry a spectrum of ideas ed. by Merton Sandler |
| title_fullStr | 5-hydroxytryptamine in psychiatry a spectrum of ideas ed. by Merton Sandler |
| title_full_unstemmed | 5-hydroxytryptamine in psychiatry a spectrum of ideas ed. by Merton Sandler |
| title_short | 5-hydroxytryptamine in psychiatry |
| title_sort | 5 hydroxytryptamine in psychiatry a spectrum of ideas |
| title_sub | a spectrum of ideas |
| topic | Récepteur sérotonine - Physiologie - Congrès Sérotonine - Physiologie - Congrès comme sujet Sérotonine - usage thérapeutique - Congrès comme sujet Trouble mental - Chimiothérapie - Congrès Trouble mental - Etiologie - Congrès Mental Disorders drug therapy Congresses Mental Disorders etiology Congresses Mental illness Physiological aspects Congresses Neuropsychiatry Congresses Receptors, Serotonin physiology Congresses Serotonin Congresses Serotonin physiology Congresses Serotonin therapeutic use Congresses Serotonin (DE-588)4054614-7 gnd Psychopharmakologie (DE-588)4176249-6 gnd |
| topic_facet | Récepteur sérotonine - Physiologie - Congrès Sérotonine - Physiologie - Congrès comme sujet Sérotonine - usage thérapeutique - Congrès comme sujet Trouble mental - Chimiothérapie - Congrès Trouble mental - Etiologie - Congrès Mental Disorders drug therapy Congresses Mental Disorders etiology Congresses Mental illness Physiological aspects Congresses Neuropsychiatry Congresses Receptors, Serotonin physiology Congresses Serotonin Congresses Serotonin physiology Congresses Serotonin therapeutic use Congresses Serotonin Psychopharmakologie Konferenzschrift 1990 San Juan Puerto Rico |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002878562&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT sandlermerton 5hydroxytryptamineinpsychiatryaspectrumofideas AT sandlermerton fivehydroxytryptamineinpsychiatry |